ValGenesis Announces DynaCompliance as Service Partner for US and India

ValGenesis Inc., the market leader in enterprise validation lifecycle management systems (VLMS), and DynaCompliance Pvt. Ltd., a compliance and validation solutions company, have partnered to strategically advance the adoption of ValGenesis' industry-leading suite of digital validation solutions for life sciences companies across India and the US.

DynaCompliance helps life sciences companies integrate the latest digital technologies and data-driven approaches into drug development, manufacturing, and validation processes, through comprehensive compliance and validation solutions.

ValGenesis is the industry innovator of digitized validation. The company's platform, which includes its flagship VLMS offering, is used in over 100,000 GMP systems worldwide, helping life sciences companies advance their digital transformation strategy, enforce compliance, and enable standardization with 100% digital, risk-based validation software.

DynaCompliance and ValGenesis offer a wide range of concept-to-commercialization digital validation solutions, including ValGenesis VLMS and VLMS Express, a simplified cloud-based digital validation solution for startups and midsized companies; Process Insight, used by the world's largest pharmaceutical, medical device, and biotechnology firms to digitize continued process verification; iRisk, the industry's most user-friendly tool for understanding and mitigating risk from R&D through commercialization; e-Logbook, a web-based platform that eliminates the frustrations of paper-based logbooks; and Process Manager, a solution that guarantees regulatory compliance and product safety through scientific validation and electronic documentation in the cleaning validation lifecycle.

"To be an innovator and stay competitive in the life sciences industry, companies must learn to harness the power of digital validation technology," says Bo Olsen, ValGenesis' SVP of Partners. "We are excited that DynaCompliance has decided to partner with ValGenesis as their preferred provider of solutions for life sciences companies to achieve their Pharma 4.0 digital transformation objectives."

"We are thrilled to partner with ValGenesis, a recognized leader in digital validation solutions," says Sheetal Patel, Managing Director and Founder of DynaCompliance Pvt. Ltd. "We understand the challenges of transitioning to paperless workflows. Over the years, we've built a reputation for creating workflows that closely resemble our clients' existing paper-based processes. This minimizes disruption and allows for faster adoption.

"By combining this expertise with ValGenesis' industry leading platform, we empower life sciences companies to achieve their digital transformation goals and navigate the evolving regulatory landscape of Pharma 4.0 and Validation 4.0. This partnership will enable us to deliver a comprehensive suite of solutions that streamline paperless validation processes, improve efficiency, and ensure data integrity."

ABOUT DYNACOMPLIANCE PVT. LTD.

DynaCompliance empowers life science companies to navigate Pharma 4.0 and Validation 4.0 environments with customizable digital solutions that ensure a smooth transition from paper-based processes to paperless workflows. The company's team of experts specialize in compliance, validation, and regulatory affairs, with a particular focus on leveraging digital technologies to enhance efficiency and quality. They offer a range of services, including process and cleaning validation, equipment qualification and verification, software validation, paperless validation, and quality management. For more information, visit https://www.dynacompliance.com/index.php

ABOUT VALGENESIS INC.

ValGenesis, Inc. is the creator of an innovative software platform that serves as a foundation for managing compliance-based validation activities in life science companies. ValGenesis, Inc. is the provider of the first enterprise application that manages the corporate validation lifecycle process. This solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. As the first fully paperless solution for electronic management of validation execution and approval, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award in 2005. For more information, visit https://www.valgenesis.com/